In contrast, the expression of cIAP2 and NF-kB in the GEM/CIS-resistant cell lines that did not develop acquire vulnerability to LCL161 (SSP25R and KKU068R) remained unchanged (Figures 3A, B, Supplementary Figure 2A). This evidence concerns the gene BIRC3 and in situ carcinoma.